000 | 01715 a2200505 4500 | ||
---|---|---|---|
005 | 20250518032750.0 | ||
264 | 0 | _c20201105 | |
008 | 202011s 0 0 eng d | ||
022 | _a2045-2322 | ||
024 | 7 |
_a10.1038/s41598-019-42245-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDong, Qiuju | |
245 | 0 | 0 |
_aPCC0208027, a novel tyrosine kinase inhibitor, inhibits tumor growth of NSCLC by targeting EGFR and HER2 aberrations. _h[electronic resource] |
260 |
_bScientific reports _c04 2019 |
||
300 |
_a5692 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aErbB Receptors _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
650 | 0 | 4 |
_aReceptor, ErbB-4 _xgenetics |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aYu, Pengfei | |
700 | 1 | _aYe, Liang | |
700 | 1 | _aZhang, Jianzhao | |
700 | 1 | _aWang, Hongbo | |
700 | 1 | _aZou, Fangxia | |
700 | 1 | _aTian, Jingwei | |
700 | 1 | _aKurihara, Hiroshi | |
773 | 0 |
_tScientific reports _gvol. 9 _gno. 1 _gp. 5692 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-019-42245-3 _zAvailable from publisher's website |
999 |
_c29557295 _d29557295 |